Skip to main content
SpringerLink
Log in

Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ghobadi A. Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma. Curr Res Transl Med. 2018;66:43–9.

    Article  Google Scholar 

  2. Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188–95.

    Article  CAS  Google Scholar 

  3. Wang LX, Chen X, Jia M, Wang S, Shen J. Arthritis of large joints shown as a rare clinical feature of cytokine release syndrome after chimeric antigen receptor T cell therapy. Medicine. 2018;97:16.

    Article  Google Scholar 

  4. So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13:639–47.

    Article  CAS  Google Scholar 

  5. Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M. CAR T-cell induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat Med. 2018;24:731–8.

    Article  CAS  Google Scholar 

  6. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 2009;460:269–73.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, University of Washington, Seattle, WA, USA

    Sarah H. Chung & Grant Hughes

  2. CLL Society, Claremont, CA, USA

    Brian Koffman

  3. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Cameron J. Turtle, David G. Maloney & Utkarsh H. Acharya

  4. Division of Medical Oncology, University of Washington, Seattle, WA, USA

    Cameron J. Turtle, David G. Maloney & Utkarsh H. Acharya

  5. Division of Cellular Therapy in Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA

    Utkarsh H. Acharya

Authors
  1. Sarah H. Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grant Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian Koffman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cameron J. Turtle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David G. Maloney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Utkarsh H. Acharya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah H. Chung.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chung, S.H., Hughes, G., Koffman, B. et al. Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy. Bone Marrow Transplant 54, 632–634 (2019). https://doi.org/10.1038/s41409-018-0357-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0357-4

  • Springer Nature Limited

Search

Navigation